InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,185.74
(
0.10%
)
US TECH 100
17,619.96
(
0.06%
)
Dow Jones
38,889.99
(
0.10%
)
Brent Oil
83.10
(
-0.46%
)
Bitcoin
63,104.91
(
-0.10%
)
Post# of 7596
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

No1Uknow

Send PM Follow Ignore
Followers 33
Posts 1496
Boards Moderated 0
Alias Born 12/06/2016

No1Uknow

Re: None

Thursday, 03/25/2021 10:48:30 AM

Thursday, March 25, 2021 10:48:30 AM

Post# of 7596
Quanta, Inc. (OTC PINK: QNTA), announced today that it has completed production of a batch of its lead drug candidate Escozine® and finalized analysis of the batch, which is now ready for submission to the US Food and Drug Administration (FDA) as a part of its Pre-Investigational New Drug (PIND #150335) filing as a potential treatment for the SARS-CoV-2 (COVID-19) virus.

Do your research, take your position, turn off the noise.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up